Thomas Salzmann

Keine laufenden Positionen mehr

Health Technology

Finance

Profil

Dr. Salzmann sits on the Board and SAB of Satori Pharmaceuticals, a PureTech portfolio company.
Previously he was Executive Vice President, Merck Research Labs.
Dr. Salzmann's career at Merck spanned nearly 30 years in which he has also held positions including EVP Worldwide Preclinical Development, Global Operations, and Project Management and SVP Basic Research and Chemistry.
He is also a member of the MRL Executive Committee.

Ehemalige bekannte Positionen von Thomas Salzmann

Unternehmen	Position	Ende
Puretech Health LLC Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements.	Private Equity Investor	30.07.2008
Satori Pharmaceuticals, Inc. Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease	Direktor/Vorstandsmitglied	-
MERCK & CO., INC.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Thomas Salzmann im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen